|
시장보고서
상품코드
1949099
단백질 라벨링 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global Protein Labeling Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
단백질 표시 시장 규모는 2025년 25억 4,000만 달러에서 2026-2034년에 CAGR 10.15%로 성장하며, 2034년에는 60억 7,000만 달러에 달할 것으로 예측되고 있습니다.
정확하고 유익한 식품 라벨링에 대한 수요가 증가함에 따라 단백질 라벨링 시장이 크게 성장할 것으로 예측됩니다. 단백질 표시는 식품의 단백질 함량에 대한 정보를 소비자에게 제공하는 데 필수적이며, 운동선수, 피트니스 애호가, 특정 건강 상태를 가진 사람 등 식단 섭취를 관리하고자 하는 사람들에게 매우 중요합니다. 영양학에서 단백질의 중요성에 대한 인식이 높아지고 건강 및 웰빙에 대한 관심이 높아지면서 단백질 라벨링 솔루션에 대한 수요가 증가하고 있습니다.
기술 혁신은 단백질 디스플레이 시장 전망를 형성하는 데 중요한 역할을 하고 있습니다. 질량분석법, 효소면역측정법(ELISA) 등 분석기술의 혁신으로 단백질 함량 분석의 정확도와 신뢰성이 향상되고 있습니다. 또한 QR코드와 모바일 애플리케이션를 포함한 디지털 디스플레이 솔루션의 개발로 소비자들이 상세한 영양 정보에 쉽게 접근할 수 있게 되었습니다. 제조업체들이 표시 방법을 지속적으로 혁신하고 개선하는 가운데, 단백질 표시 시장은 다양한 식품 및 음료 분야에서 채택이 확대될 것으로 예측됩니다.
또한 규제 준수와 투명성에 대한 관심이 높아지면서 단백질 라벨링 시장의 성장 궤도에 영향을 미치고 있습니다. 각국 정부가 식품 표시 및 영양 표시 관련 규제를 강화함에 따라 정확하고 규정을 준수하는 단백질 표시 솔루션에 대한 수요가 증가할 것으로 예측됩니다. 이러한 추세에 따라 표시 기준 준수와 소비자 신뢰 증진을 위해 식품 제조업체, 규제기관, 기술 프로바이더 간의 협력이 진행되고 있습니다. 시장이 계속 진화하는 가운데, 기술, 컴플라이언스, 소비자 교육의 통합이 성공의 열쇠가 될 것입니다.
목차
제1장 서론
제2장 개요
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 단백질 라벨링 시장 : 제품별
제5장 세계의 단백질 라벨링 시장 : 라벨링 방법별
제6장 세계의 단백질 라벨링 시장 : 용도별
제7장 세계의 단백질 라벨링 시장 : 최종사용자별
제8장 세계의 단백질 라벨링 시장 : 지역별
제9장 경쟁 구도
제10장 기업 개요
KSA 26.03.10The Protein Labeling Market size is expected to reach USD 6.07 Billion in 2034 from USD 2.54 Billion (2025) growing at a CAGR of 10.15% during 2026-2034.
The Protein Labeling Market is poised for significant growth as the demand for accurate and informative food labeling increases. Protein labeling is essential for providing consumers with information about the protein content in food products, which is crucial for those seeking to manage their dietary intake, such as athletes, fitness enthusiasts, and individuals with specific health conditions. The rising awareness of the importance of protein in nutrition, coupled with the growing trend towards health and wellness, is driving the demand for protein labeling solutions.
Technological advancements are playing a crucial role in shaping the future of the protein labeling market. Innovations in analytical techniques, such as mass spectrometry and enzyme-linked immunosorbent assays (ELISA), are enhancing the accuracy and reliability of protein content analysis. Additionally, the development of digital labeling solutions, including QR codes and mobile applications, is improving consumer access to detailed nutritional information. As manufacturers continue to innovate and enhance their labeling practices, the protein labeling market is likely to see increased adoption across various food and beverage sectors.
Moreover, the growing emphasis on regulatory compliance and transparency is influencing the protein labeling market's growth trajectory. As governments implement stricter regulations regarding food labeling and nutritional claims, the demand for accurate and compliant protein labeling solutions is expected to rise. This trend is driving collaboration between food manufacturers, regulatory bodies, and technology providers to ensure adherence to labeling standards and promote consumer trust. As the market continues to evolve, the integration of technology, compliance, and consumer education will be key drivers of success.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Product
- Reagents
- Kits
- Services
By Labeling Method
- In Vitro Labeling
- In Vivo Labeling
By Application
- Cell-Based Assays
- Fluorescence Microscopy
- Immunological Techniques
- Mass Spectrometry
- Protein Microarray
By End-User
- Academic Research Institutes
- Hospitals
- Diagnostic Centers
- Pharmaceutical And Biotechnology Companies
COMPANIES PROFILED
- Thermo Fisher Scientific Inc, Merck KGaA, PerkinElmer Inc, GE Healthcare, Promega Corporation, LICOR Biosciences, New England Biolabs, F HoffmannLa Roche Ltd, BioRad Laboratories Inc, Agilent Technologies Inc, Abcam plc, GenScript Biotech Corporation, Takara Bio Inc, Enzo Life Sciences Inc, Rockland Immunochemicals Inc
We can customise the report as per your requriements
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL PROTEIN LABELING MARKET: BY PRODUCT 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Product
- 4.2. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL PROTEIN LABELING MARKET: BY LABELING METHOD 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Labeling Method
- 5.2. In Vitro Labeling Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. In Vivo Labeling Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL PROTEIN LABELING MARKET: BY APPLICATION 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast Application
- 6.2. Cell-Based Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Fluorescence Microscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Immunological Techniques Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.5. Mass Spectrometry Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.6. Protein Microarray Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL PROTEIN LABELING MARKET: BY END-USER 2022-2034 (USD MN)
- 7.1. Market Analysis, Insights and Forecast End-user
- 7.2. Academic Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.4. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.5. Pharmaceutical And Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 8. GLOBAL PROTEIN LABELING MARKET: BY REGION 2022-2034(USD MN)
- 8.1. Regional Outlook
- 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Product
- 8.2.2 By Labeling Method
- 8.2.3 By Application
- 8.2.4 By End-user
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
- 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Product
- 8.3.2 By Labeling Method
- 8.3.3 By Application
- 8.3.4 By End-user
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
- 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Product
- 8.4.2 By Labeling Method
- 8.4.3 By Application
- 8.4.4 By End-user
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
- 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Product
- 8.5.2 By Labeling Method
- 8.5.3 By Application
- 8.5.4 By End-user
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 South East Asia
- 8.5.10 Rest of Latin America
- 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Product
- 8.6.2 By Labeling Method
- 8.6.3 By Application
- 8.6.4 By End-user
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa
Chapter 9. COMPETITIVE LANDSCAPE
- 9.1. Recent Developments
- 9.2. Company Categorization
- 9.3. Supply Chain & Channel Partners (based on availability)
- 9.4. Market Share & Positioning Analysis (based on availability)
- 9.5. Vendor Landscape (based on availability)
- 9.6. Strategy Mapping
Chapter 10. COMPANY PROFILES OF GLOBAL PROTEIN LABELING INDUSTRY
- 10.1. Top Companies Market Share Analysis
- 10.2. Company Profiles
- 10.2.1 Thermo Fisher Scientific Inc
- 10.2.2 Merck KGaA
- 10.2.3 PerkinElmer Inc
- 10.2.4 GE Healthcare
- 10.2.5 Promega Corporation
- 10.2.6 LI-COR Biosciences
- 10.2.7 New England Biolabs
- 10.2.8 F. Hoffmann-La Roche Ltd
- 10.2.9 Bio-Rad Laboratories Inc
- 10.2.10 Agilent Technologies Inc
- 10.2.11 Abcam Plc
- 10.2.12 GenScript Biotech Corporation
- 10.2.13 Takara Bio Inc
- 10.2.14 Enzo Life Sciences Inc
- 10.2.15 Rockland Immunochemicals Inc
